Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Inventory (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Inventory for 6 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory fell 47.55% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2025, down 47.55%, and an annual FY2025 reading of $2.2 million, up 153.89% over the prior year.
  • Inventory was $1.0 million for Q4 2025 at Neuroone Medical Technologies, down from $2.2 million in the prior quarter.
  • Across five years, Inventory topped out at $2.2 million in Q3 2025 and bottomed at $52182.0 in Q2 2021.
  • Average Inventory over 5 years is $1.0 million, with a median of $1.0 million recorded in 2025.
  • The sharpest move saw Inventory soared 1558.33% in 2021, then tumbled 55.76% in 2025.
  • Year by year, Inventory stood at $229115.0 in 2021, then skyrocketed by 294.37% to $903554.0 in 2022, then surged by 78.04% to $1.6 million in 2023, then increased by 20.03% to $1.9 million in 2024, then plummeted by 47.55% to $1.0 million in 2025.
  • Business Quant data shows Inventory for NMTC at $1.0 million in Q4 2025, $2.2 million in Q3 2025, and $793383.0 in Q2 2025.